Compositions and methods for local delivery of pharmaceutical agents to treat cancer
AssigneeThe General Hospital Corporation
InventorShadmehr Demehri
Life of this patent
Estimating the term…
Abstract
Described herein are compositions comprising a T cell/thymic stromal lymphopoietin (TSLP) activating agent and an innate immunity activating agent, an methods of use thereof to treat cancer, e.g., cutaneous malignancies.
Claims16
A method for treating a proliferative disorder in the skin of a subject in need thereof, said method comprising administering a therapeutically effective amount of (i) an agent that activates T cells through TSLP induction and (ii) an innate immune cell activating agent, preferably directly to a site of proliferation in the skin of the subject, thereby treating the proliferative disorder in the skin of the subject.
-29. (canceled)
Dependencies are inferred from the claim text.